Testicular cancer survivors face hidden heart risks – study seeks answers

NCT ID NCT02276430

Ongoing Knowledge-focused Sponsor: University Medical Center Groningen Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study follows nearly 1,000 testicular cancer survivors to understand why they have a higher risk of heart disease. Researchers are looking at how cancer treatments like chemotherapy may damage blood vessels or lead to risk factors like high blood pressure. The goal is to improve long-term care for young men who beat testicular cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify which testicular cancer survivors are at higher risk for heart disease and create better follow-up care plans.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly change patient care. Results may take years to influence guidelines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TESTICULAR CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder testicular cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TESTICULAR CANCER

Contacts and locations

Locations

Antoni van Leeuwenhoek Hospital

Amsterdam, Netherlands
University Medical Center Groningen

Groningen, 9700 RB, Netherlands
University Medical Center St. Radboud

Nijmegen, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.